Business Wire

CA-ANDERSEN-GLOBAL

5.5.2021 14:16:05 CEST | Business Wire | Pressemeddelelse

Del
Andersen Global udvider sit europæiske fodfæste med rådgivningsfirma i Monaco

Andersen Global styrker sin tilstedeværelse i Vesteuropa gennem en samarbejdsaftale med rådgivningsfirma i Monaco EBC Trust, dermed komplementeres den globale organisations Private Client-rådgivning praksis og evne til at opfylde klienters behov på tværs af landegrænser gennem sine medlemmer og samarbejdsfirmaer.

EBC Trust blev etableret i 1975 og specialiserer sig i rådgivning til erhvervs- og privatkunder med den ledende partner Richard Maclellan i spidsen. Deres fokusområder omfatter aktiv ledelse af klienters underliggende aktiver og ligeledes regnskabs- og anmeldelsestjenester. Teamet som består af syv medarbejdere, har driftsmæssige, økonomiske og regulatoriske erfaringer, som er autoriserede til at levere tjenester som formueforvaltning i Monaco og erklæringer om reelt ejerskab for Monacos ejendomshandlere. Derudover hjælper de klienter med etablering af afdeling for familieanliggender, overholdelse af skatteregler, planlægning af pensionering og succession samt flytning til Monaco.

"Vores prioritet er og vil fortsat være kundeservice i særklasse", udtalte Richard. "Vores pligtopfyldenhed, når det gælder ledelse og forpligtelse til gennemsigtighed, gør det muligt for os at levere uafhængig rådgivning og skræddersyede tjenester, der er i dine kunders bedste interesse. Samarbejdet med Andersen Global forbedrer vores tjenestetilbud yderligere, idet vi kan tilvejebringe klienter med problemfri løsninger og ressourcerne i en global organisation. Vi ser frem til at arbejde med Andersen Globals medlemmer og samarbejdsfirmaer i Europa såvel som globalt, og til at etablere synergistiske arbejdsrelationer."

"Monaco er et betydeligt marked og vores samarbejde med EBC Trust sætter os i en position, hvor vi kan levere endnu mere omfattende løsninger til klienter og tilføje dækning for vores organisation i Vesteuropa", sagde Andersen Global bestyrelsesformand og adm. direktør Mark Vorsatz. "Richard og hans team har en enestående viden og erfaring, som gjorde dem til den ideelle tilføjelse til vores platform i regionen. Deres fremragende omdømme, virksomhedskultur og ligesindethed vil gøre det muligt for dem at arbejde synergistisk med vores andre medlemsfirmaer og samarbejdsfirmaer globalt."

Andersen Global er en international sammenslutning af juridisk adskilte, uafhængige medlemsfirmaer bestående af skatte- og juraeksperter fra hele verden. Efter at være blevet etableret i 2013 af det amerikanske medlemsfirma Andersen Tax LLC, har Andersen Global nu over 7.000 eksperter globalt og er repræsenteret på mere end 265 lokaliteter via sine medlems- og samarbejdsfirmaer.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye